The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 21, 2025

Filed:

May. 26, 2020
Applicant:

Toray Industries, Inc., Tokyo, JP;

Inventors:

Kenichi Harimoto, Otsu, JP;

Kanta Tanabe, Otsu, JP;

Kazuhiro Tanahashi, Otsu, JP;

Hirokazu Sakaguchi, Otsu, JP;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C08L 67/04 (2006.01); A61L 27/26 (2006.01); A61L 27/58 (2006.01); C08G 63/08 (2006.01); C08G 63/78 (2006.01);
U.S. Cl.
CPC ...
C08L 67/04 (2013.01); A61L 27/26 (2013.01); A61L 27/58 (2013.01); C08G 63/08 (2013.01); C08G 63/78 (2013.01); A61L 2300/604 (2013.01); A61L 2430/32 (2013.01); C08L 2203/02 (2013.01); C08L 2203/18 (2013.01); C08L 2205/02 (2013.01);
Abstract

A polymer composition contains polylactic acid and a dilactide/ε-caprolactone copolymer, in which a content of the polylactic acid relative to a total of 100 mass % of the polylactic acid and the dilactide/ε-caprolactone copolymer is 20 to 40 mass %, and in which the dilactide/ε-caprolactone copolymer satisfies (1) an R value represented by a following formula is 0.45 or more and 0.99 or less: where [A] is a molar fraction (%) of a dilactide residue in the dilactide/ε-caprolactone copolymer, [B] is a molar fraction (%) of an ε-caprolactone residue in the dilactide/ε-caprolactone copolymer, and [AB] is a molar fraction (%) of a structure in which a dilactide residue and an ε-caprolactone residue are adjacent to each other (A-B and B-A) in the dilactide/ε-caprolactone copolymer, and (2) at least one of the dilactide residue and the ε-caprolactone residue has a degree of crystallization of less than 14%.


Find Patent Forward Citations

Loading…